Interim results of motor-symptom endpoints of an ongoing, open-label study of levodopa-carbidopa intestinal gel in Parkinson's disease patients with severe motor fluctuations

被引：0
|
作者：
Espay, A. J.
Chatamra, K.
Fernandez, H. H.
Standaert, D. G.
Hauser, R. A.
Benesh, J.
Caras, S. D.
Pritchett, Y. L.
Lenz, R. A.
机构：
来源：
MOVEMENT DISORDERS | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
375
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [31] LONG-TERM MOTOR AND NON-MOTOR SYMPTOM BENEFITS IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE TREATED WITH LEVODOPA-CARBIDOPA INTESTINAL GEL: DUOGLOBE FINAL ANALYSIS
    Chaudhuri, K. R.
    Kovacs, N.
    Pontieri, F. E.
    Aldred, J.
    Bourgeois, P.
    Davis, T. L.
    Cubo, E.
    Anca-Herschkovitsch, M.
    Iansek, R.
    Siddiqui, M. S.
    Simu, M.
    Bergmann, L.
    Kukreja, P.
    Ladhani, O.
    Jia, J.
    Standaert, D. G.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 37 - 37
  • [32] Continuous levodopa-carbidopa gel recovers motor cortex plasticity in advanced Parkinson's disease
    Kolmancic, K.
    Prezelj, N.
    Zupancic, N. Kriznar
    Trost, M.
    Flisar, D.
    Kramberger, M. Gregoric
    Rajnar, R.
    Pirtosek, Z.
    Kojovic, M.
    MOVEMENT DISORDERS, 2019, 34
  • [33] Continuous levodopa-carbidopa gel recovers motor cortex plasticity in advanced Parkinson's disease
    Kolmancic, K.
    Prezelj, N.
    Kriznar, N. Zupancic
    Trost, M.
    Flisar, D.
    Kramberger, M. G.
    Rajnar, R.
    Pirtosek, Z.
    Kojovic, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 772 - 773
  • [34] Titration of Levodopa-Carbidopa Intestinal Gel in US Patients with Advanced Parkinson's Disease
    Aldred, Jason
    Davis, Thomas
    Zamudio, Jorge
    Kukreja, Pavnit
    Bergmann, Lars
    Li, Mei
    Standaert, David
    MOVEMENT DISORDERS, 2018, 33 : S93 - S93
  • [35] Comment on: “Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review”
    Andrew T. Lambarth
    CNS Drugs, 2016, 30 : 1007 - 1008
  • [36] Comment on: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review"
    Lambarth, Andrew T.
    CNS DRUGS, 2016, 30 (10) : 1007 - 1008
  • [37] Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel
    Solla, Paolo
    Cannas, Antonino
    Marrosu, Maria Giovanna
    Marrosu, Francesco
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (11) : 1383 - 1384
  • [38] Percutaneous Endoscopic Gastrojejunostomy as a Novel Method of Drug Delivery for the Treatment of Parkinson's Disease: Interim Results of an Open-Label, Long-Term Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel
    Vanagunas, Arvydas
    Smallfield, George
    Schmulewitz, Nathan
    Crookes, Peter
    Benesh, Janet
    Freeman, Stefanie
    Robieson, Weining
    Chatamra, Krai
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S545 - S545
  • [39] Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
    Antonini, Angelo
    Fung, Victor S. C.
    Boyd, James T.
    Slevin, John T.
    Hall, Coleen
    Chatamra, Krai
    Eaton, Susan
    Benesh, Janet A.
    MOVEMENT DISORDERS, 2016, 31 (04) : 530 - 537
  • [40] Weight, BMI, and Dyskinesia in Patients With Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel
    Pontieri, F.
    Bourgeois, P.
    Chaudhuri, K.
    Siddiqui, M.
    Bergmann, L.
    Kukreja, P.
    Ladhani, O.
    Simu, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 230 - 230
12345